how effective is intravenous glutathione compared to oral supplements IV Therapy Philadelphia Glutathione for Skin: IV vs.
Description
J., Greenfield N
N Engl J Med 334(18):11561162
The decreased expression of ATGL inhibits fatty acid mobilization of intracellular lipid droplets and promotes lipid droplet's aggregation, leading to renal tubular epithelial cell injury and renal fibrosis, and ultimately promotes the transformation of AKI to CKD[27]
Guidelines from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) prioritize the use of GLP-1 RAs for patients with DKD who have cardiovascular comorbidities
